Distinct association between aberrant methylation of Wnt inhibitors and genetic alterations in acute myeloid leukaemia
Open Access
- 17 November 2011
- journal article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 105 (12), 1927-1933
- https://doi.org/10.1038/bjc.2011.471
Abstract
Aberrant activation of Wnt signalling through hypermethylation of Wnt inhibitor genes is involved in several human malignancies, including acute myeloid leukaemia (AML). It remains unclear whether hypermethylation of Wnt inhibitors is associated with molecular gene mutations in the development of AML. We investigated the association of the promoter hypermethylation of six Wnt inhibitors (Wif-1, SFRP1, SFRR2, SFRP4, SFRP5, and DKK1) with gene aberrations in the leukaemogenesis of 269 AML patients. In total, 166 patients (61.7%) had hypermethylation of at least one Wnt inhibitor. The majority (68.5%) of patients with Wnt inhibitor hypermethylation had concurrent Class II gene mutations that affect transcription factors or cofactors. There was a close association of Wif-1 hypermethylation with t(15;17) (P=0.0005) and CEBPA mutation (P<0.0001), DKK1 hypermethylation with t(8;21) (P<0.0001) and ASXL1 mutation (P=0.0078), SFRP-1 hypermethylation with t(8;21) (P<0.0001), SFRP-2 hypermethylation with AML1/RUNX1 mutation (P=0.0012), and SFRP-5 hypermethylation with MLL/PTD (P=0.0505). On the other side, hypermethylation of Wnt inhibitors was always negatively associated with NPM1 mutation and FLT3/ITD. There was distinct association between hypermethylation of individual Wnt inhibitors and specific gene aberrations, especially Class II mutations. The Wnt inhibitor hypermethylation might interact with genetic alterations in the leukaemogenesis.Keywords
This publication has 45 references indexed in Scilit:
- The Wnt/β-Catenin Pathway Is Required for the Development of Leukemia Stem Cells in AMLScience, 2010
- Epigenetic inactivation of secreted Frizzled‐related proteins in acute myeloid leukaemiaBritish Journal of Haematology, 2008
- Acquisition of JAK2, PTPN11, and RAS mutations during disease progression in primary myelodysplastic syndromeLeukemia, 2006
- Wnt signalling in stem cells and cancerNature, 2005
- Molecular genetics of human leukemias: New insights into therapySeminars in Hematology, 2002
- The Human Genome Browser at UCSCGenome Research, 2002
- Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinomaProceedings of the National Academy of Sciences, 1998
- Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon CarcinomaScience, 1997
- Cytogenetic studies, ras mutation, and clinical characteristics in primary myelodysplastic syndrome: A study on 68 Chinese patients in TaiwanCancer Genetics and Cytogenetics, 1994
- CpG Islands in vertebrate genomesJournal of Molecular Biology, 1987